Bliss GVS Pharma reports consolidated net loss of Rs 13.72 crore in the March 2018 quarter

Sales decline 33.28% to Rs 165.32 crore

Net loss of Bliss GVS Pharma reported to Rs 13.72 crore in the quarter ended March 2018 as against net profit of Rs 42.60 crore during the previous quarter ended March 2017. Sales declined 33.28% to Rs 165.32 crore in the quarter ended March 2018 as against Rs 247.79 crore during the previous quarter ended March 2017.

For the full year,net profit declined 21.32% to Rs 88.66 crore in the year ended March 2018 as against Rs 112.68 crore during the previous year ended March 2017. Sales rose 4.42% to Rs 806.45 crore in the year ended March 2018 as against Rs 772.29 crore during the previous year ended March 2017.

ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales165.32247.79 -33 806.45772.29 4 OPM %22.7130.71 -24.4526.25 - PBDT37.6361.57 -39 200.87195.55 3 PBT32.7660.40 -46 179.49175.40 2 NP-13.7242.60 PL 88.66112.68 -21

Powered by Capital Market - Live News